Progressive Care Completes Move to New Facility, Begins Expansion Into Long-Term Care Pharmacy Market
Miami, FL, Dec. 23, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”),...
Miami, FL, Dec. 23, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”),...
--Dr. Dunne resigns as Chief Scientific Officer-- -- Steven Aronin, M.D., Senior Vice President and Head of Clinical Development, to...
The Company began enrolling patients in Saturn-1 in September 2020 and expects to initiate its second pivotal registration trial, Saturn-2,...
The release of BBS-Bioactive Bone Substitutes' financial calendar and Annual General Meeting in 2021 published by BBS-Bioactive Bone Substitutes Plc...
ALACHUA, Fla., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
OTTAWA, Dec. 23, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection...
Stockholm 2020-12-23: Aino Health announces today that they have signed a new customer agreement with the Swedish company Curira. The...
Long Beach, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release...
Novadip Biosciences Receives Rare Paediatric Disease Priority Review and Orphan Disease Designation Dual designations granted for NVD-003 for the Treatment...
Amryt Granted Orphan Drug Designation by the FDA for AP103 DUBLIN, Ireland, and Boston MA, December 23, 2020, Amryt (Nasdaq:...
VANCOUVER, Dec. 22, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) CSE: BETR / OTCQB: BETRF /...
COPENHAGEN, Denmark, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Evaxion Biotech, a clinical-stage biotechnology company developing AI-driven immunotherapies, announces today the...
Will Trade on the Nasdaq Global Market Under Ticker “GBS”NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) -- GBS Inc. (the...
Annual Meeting to be adjourned solely with respect to Item 2, and Item 2 to be modified to decrease the...
Subcutaneous administration is preferred by patients, physicians and healthcare providers, and is associated with a reduction in healthcare costs1,2,3Treatment with...
VANCOUVER, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is proud to announce the launch of his new...
VANCOUVER, British Columbia, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is proud to announce the launch of a new...
SAN DIEGO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that an Emergency Use...
Met primary endpoint with robust statistical significanceShowed efficacy on both hyperactivity/impulsivity and inattention subscales with statistical significanceShowed statistically significant onset...
Improves liquidity and operating flexibilitySignificantly reduces borrowing costsSupports ongoing transformation to profitable growth platformHOLLISTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE)...